GENTAMICIN RANDOM

LAB27

GENT R

Collect

4.5 mL green top with gel (PST), plasma (lithium heparin).

Pediatric Collection

0.5 mL whole blood collected in a green top with gel Microtainer.

Unacceptable Conditions

Specimen not properly identified; incorrect container; insufficient sample volume; specimen thawed more than once.

Storage/Transport Temperature

Internal: Deliver to lab immediately.
Offsite: Separate serum or plasma from cells. Send at 2-8 C. Freeze at - 20 C if not analyzed within 24 hours.

Stability (from collection to initiation)

Stable for 24 hours at 2-8 C. Freeze at -20 C if not analyzed wiithin 24 hours.

Remarks

Indicate dosage information. Random levels cannot be interpreted.

Performed by

PCL Clinical Laboratory - Core Chemistry

Performed

Upon receipt

Methodology

Chemiluminescent immunoassay

Reported

Same day

Synonyms

  • Garamycin Random
  • -304
  • LAB27

Interpretive Data

Random levels cannot be interpreted. Call Infectious Diseases Fellow for
assistance.

Performed by

PCL Clinical Laboratory - Core Chemistry

CPT Codes

80170

Collection

LAB27

GENT R

Collect

4.5 mL green top with gel (PST), plasma (lithium heparin).

Pediatric Collection

0.5 mL whole blood collected in a green top with gel Microtainer.

Unacceptable Conditions

Specimen not properly identified; incorrect container; insufficient sample volume; specimen thawed more than once.

Storage/Transport Temperature

Internal: Deliver to lab immediately.
Offsite: Separate serum or plasma from cells. Send at 2-8 C. Freeze at - 20 C if not analyzed within 24 hours.

Stability (from collection to initiation)

Stable for 24 hours at 2-8 C. Freeze at -20 C if not analyzed wiithin 24 hours.

Remarks

Indicate dosage information. Random levels cannot be interpreted.

Performed by

PCL Clinical Laboratory - Core Chemistry

Ordering

Performed

Upon receipt

Methodology

Chemiluminescent immunoassay

Reported

Same day

Synonyms

  • Garamycin Random
  • -304
  • LAB27
Result Interpretation

Interpretive Data

Random levels cannot be interpreted. Call Infectious Diseases Fellow for
assistance.

Performed by

PCL Clinical Laboratory - Core Chemistry

Administrative

CPT Codes

80170

GENTAMICIN TROUGH

LAB26

GENT T

Collect

4.5 mL green top with gel (PST), plasma (lithium heparin).

Pediatric Collection

0.5 mL whole blood collected into a green top with gel Microtainer.

Unacceptable Conditions

Specimen not properly identified; incorrect container; insufficient sample volume; specimen thawed more than once.

Storage/Transport Temperature

Internal: Deliver to lab immediately.
Offsite: Separate serum or plasma from cells and send at 2-8 C.
Freeze at -20 C if not to be analyzed within 24 hours.

Stability (from collection to initiation)

Stable for 24 hours at 2-8 C. Freeze at -20 C if not to be analyzed within 24 hours.

Remarks

Trough levels should be drawn immediately before the next dose.

Performed by

PCL Clinical Laboratory - Core Chemistry

Performed

Upon receipt

Methodology

Chemiluminescent immunoassay

Reported

Same day

Synonyms

  • Garamycin Trough
  • LAB26

Interpretive Data

REFERENCE RANGES
For Q8 dosing, trough levels should be <2 ug/mL.
For QD dosing, trough levels should be <1 ug/mL, with the level indicating a potential adjustment in dose if >2 ug/mL.

Performed by

PCL Clinical Laboratory - Core Chemistry

CPT Codes

80170

Collection

LAB26

GENT T

Collect

4.5 mL green top with gel (PST), plasma (lithium heparin).

Pediatric Collection

0.5 mL whole blood collected into a green top with gel Microtainer.

Unacceptable Conditions

Specimen not properly identified; incorrect container; insufficient sample volume; specimen thawed more than once.

Storage/Transport Temperature

Internal: Deliver to lab immediately.
Offsite: Separate serum or plasma from cells and send at 2-8 C.
Freeze at -20 C if not to be analyzed within 24 hours.

Stability (from collection to initiation)

Stable for 24 hours at 2-8 C. Freeze at -20 C if not to be analyzed within 24 hours.

Remarks

Trough levels should be drawn immediately before the next dose.

Performed by

PCL Clinical Laboratory - Core Chemistry

Ordering

Performed

Upon receipt

Methodology

Chemiluminescent immunoassay

Reported

Same day

Synonyms

  • Garamycin Trough
  • LAB26
Result Interpretation

Interpretive Data

REFERENCE RANGES
For Q8 dosing, trough levels should be <2 ug/mL.
For QD dosing, trough levels should be <1 ug/mL, with the level indicating a potential adjustment in dose if >2 ug/mL.

Performed by

PCL Clinical Laboratory - Core Chemistry

Administrative

CPT Codes

80170

GI PCR PANEL PLUS

LAB8905
GI PCR

Collect

Collect liquid or semi-solid stool in Cary-Blair Transport Media.

Unacceptable Conditions

Specimen not properly identified; insufficient sample volume; incorrect container; more than one stool specimen per day. Testing on specimens submitted from patients seven days or less from previous GI PCR PANEL PLUS testing will not be performed.

Send only one stool for bacterial culture per episode of diarrhea.

Formed stools are not suitable. Specimens in diapers or tissue paper are unacceptable.

Storage/Transport Temperature

Internal: Cary-Blair: Deliver to lab within 72 hours of collection at ambient or refrigerated temperature.

Offsite: Cary-Blair: Deliver to lab within 72 hours of collection at ambient or refrigerated temperature.

Remarks

Test includes Multiplex Film Array PCR-based identification or culture-based isolation and identification of the following bacterial, parasitic or viral pathogens:

Bacterial (PCR-based ID): Campylobacter jejuni/coli/upsaliensis, toxigenic Clostridium difficile, Salmonella, Yersinia enterocolitica, Enteroaggregative E. coli (EAEC), Enteropathogenic E. coli (EPEC), Enterotoxigenic E. coli (ETEC), Shiga-like toxin producing E. coli including E. coli O157:H7, Shigella/Enteroinvasive E. coli (EIEC).

Bacterial (culture-based ID): Aeromonas

Parasitic (PCR-based ID): Cryptosporidium and Giardia lamblia

Viral (PCR-based ID): Adenovirus F40/F41, Astrovirus, Norovirus GI/GII, Rotavirus A, Saprovirus

Culture and susceptibility testing reflexively performed for specimens testing positive for Salmonella OR Shigella/EIEC. Specimens containing interfering substances (e.g. castor oil, bismuth, barium, etc.), or delayed in transport, or contaminated with urine may not have optimal yield for culture.

Performed by

PCL Clinical Laboratory – Molecular Diagnostics and Microbiology

Notes

To rule out C. difficile:  Please order LAB3716 CDIFFICILE TOXIN PCR instead of LAB8905 GI PCR Panel Plus.

Performed

Daily

Methodology

Culture and Multiplex Film Array

Reported

Within 24h for multiplex Film Array, culture up to 72h

Synonyms

  • Stool Culture
  • C Stool
  • GI

Reference Interval

Not Detected (Multiplex Film Array)

Performed by

PCL Clinical Laboratory – Molecular Diagnostics and Microbiology

CPT Codes

87507

Collection

LAB8905
GI PCR

Collect

Collect liquid or semi-solid stool in Cary-Blair Transport Media.

Unacceptable Conditions

Specimen not properly identified; insufficient sample volume; incorrect container; more than one stool specimen per day. Testing on specimens submitted from patients seven days or less from previous GI PCR PANEL PLUS testing will not be performed.

Send only one stool for bacterial culture per episode of diarrhea.

Formed stools are not suitable. Specimens in diapers or tissue paper are unacceptable.

Storage/Transport Temperature

Internal: Cary-Blair: Deliver to lab within 72 hours of collection at ambient or refrigerated temperature.

Offsite: Cary-Blair: Deliver to lab within 72 hours of collection at ambient or refrigerated temperature.

Remarks

Test includes Multiplex Film Array PCR-based identification or culture-based isolation and identification of the following bacterial, parasitic or viral pathogens:

Bacterial (PCR-based ID): Campylobacter jejuni/coli/upsaliensis, toxigenic Clostridium difficile, Salmonella, Yersinia enterocolitica, Enteroaggregative E. coli (EAEC), Enteropathogenic E. coli (EPEC), Enterotoxigenic E. coli (ETEC), Shiga-like toxin producing E. coli including E. coli O157:H7, Shigella/Enteroinvasive E. coli (EIEC).

Bacterial (culture-based ID): Aeromonas

Parasitic (PCR-based ID): Cryptosporidium and Giardia lamblia

Viral (PCR-based ID): Adenovirus F40/F41, Astrovirus, Norovirus GI/GII, Rotavirus A, Saprovirus

Culture and susceptibility testing reflexively performed for specimens testing positive for Salmonella OR Shigella/EIEC. Specimens containing interfering substances (e.g. castor oil, bismuth, barium, etc.), or delayed in transport, or contaminated with urine may not have optimal yield for culture.

Performed by

PCL Clinical Laboratory – Molecular Diagnostics and Microbiology

Notes

To rule out C. difficile:  Please order LAB3716 CDIFFICILE TOXIN PCR instead of LAB8905 GI PCR Panel Plus.
Ordering

Performed

Daily

Methodology

Culture and Multiplex Film Array

Reported

Within 24h for multiplex Film Array, culture up to 72h

Synonyms

  • Stool Culture
  • C Stool
  • GI
Result Interpretation

Reference Interval

Not Detected (Multiplex Film Array)

Performed by

PCL Clinical Laboratory – Molecular Diagnostics and Microbiology

Administrative

CPT Codes

87507

GIARDIA/CRYPTOSPORIDIUM AG

LAB1319

Collect

Fresh stool or stool preserved in formalin (pink) and Zinc-PVA (gray)

Minimum volume: 1mL

Unacceptable Conditions

Stool older than 48 hours. Formalized stool older than 2 months.

Storage/Transport Temperature

Internal: Deliver to lab immediately
Offsite: 1. Refrigerate fresh stool specimen. Send to the lab within 24 hours. Freeze fresh stool specimen at -20 C or below in a non-defrosting freezer if testing cannot be done within 48 hours. 2. Preserve stool in formalin.

Stability (from collection to initiation)

Formalized specimens are stabile for 2 months.
Fresh stool should be tested within 48 hours.

Remarks

Test is done Monday thru Friday.
This test is recommended as a screening test before a complete Ova and Parasite test is ordered.

Testing on specimens submitted from patients concurrently with, or within seven days of GI PCR PANEL PLUS testing will not be performed.

Performed by

PCL Clinical Laboratory Microbiology

Performed

Daily, dayshift

Methodology

Immunoassay for the detection of Giardia and Cryprosporidium

Reported

Same day

Synonyms

  • LAB1319

Performed by

PCL Clinical Laboratory Microbiology

CPT Codes

87328; 87329

Collection

LAB1319

Collect

Fresh stool or stool preserved in formalin (pink) and Zinc-PVA (gray)

Minimum volume: 1mL

Unacceptable Conditions

Stool older than 48 hours. Formalized stool older than 2 months.

Storage/Transport Temperature

Internal: Deliver to lab immediately
Offsite: 1. Refrigerate fresh stool specimen. Send to the lab within 24 hours. Freeze fresh stool specimen at -20 C or below in a non-defrosting freezer if testing cannot be done within 48 hours. 2. Preserve stool in formalin.

Stability (from collection to initiation)

Formalized specimens are stabile for 2 months.
Fresh stool should be tested within 48 hours.

Remarks

Test is done Monday thru Friday.
This test is recommended as a screening test before a complete Ova and Parasite test is ordered.

Testing on specimens submitted from patients concurrently with, or within seven days of GI PCR PANEL PLUS testing will not be performed.

Performed by

PCL Clinical Laboratory Microbiology

Ordering

Performed

Daily, dayshift

Methodology

Immunoassay for the detection of Giardia and Cryprosporidium

Reported

Same day

Synonyms

  • LAB1319
Result Interpretation

Performed by

PCL Clinical Laboratory Microbiology

Administrative

CPT Codes

87328; 87329

GLOMERULAR BASEMENT MEMB IGG

LAB4710

Collect

Serum separator tube.

Specimen Preparation

Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL)

Storage/Transport Temperature

Refrigerated.

Stability (from collection to initiation)

After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)

Performed

Mon-Fri

Methodology

Semi-Quantitative Multiplex Bead Assay/Qualitative Indirect Fluorescent Antibody

Reported

1-5 days

Ordering Recommendations

Preferred panel for detecting glomerular basement membrane (GBM) antibodies in suspected or established anti-GBM disease. If positive, may be useful for monitoring treatment response.

Reference Interval

ComponentsReference Interval
Glomerular Basement Membrane Antibody, IgG by Multiplex Bead AssayNegative: 19 AU/mL or less
Equivocal: 20-25 AU/mL
Positive: 26 AU/mL or greater
Glomerular Basement Membrane Antibody, IgG (IFA)Negative

Interpretive Data

When present, IgG antibody to glomerular basement membrane (GBM) antigen detected by either indirect fluorescent antibody (IFA) or multiplex bead assay helps support a diagnosis of Goodpasture syndrome.  However, the combined result of both assays performed during initial evaluation improves the diagnostic sensitivity for disease. A positive result in one or both assays should be confirmed by renal biopsy.

CPT Codes

83516; 86255
Collection

LAB4710

Collect

Serum separator tube.

Specimen Preparation

Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL)

Storage/Transport Temperature

Refrigerated.

Stability (from collection to initiation)

After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Ordering

Performed

Mon-Fri

Methodology

Semi-Quantitative Multiplex Bead Assay/Qualitative Indirect Fluorescent Antibody

Reported

1-5 days

Ordering Recommendations

Preferred panel for detecting glomerular basement membrane (GBM) antibodies in suspected or established anti-GBM disease. If positive, may be useful for monitoring treatment response.
Result Interpretation

Reference Interval

ComponentsReference Interval
Glomerular Basement Membrane Antibody, IgG by Multiplex Bead AssayNegative: 19 AU/mL or less
Equivocal: 20-25 AU/mL
Positive: 26 AU/mL or greater
Glomerular Basement Membrane Antibody, IgG (IFA)Negative

Interpretive Data

When present, IgG antibody to glomerular basement membrane (GBM) antigen detected by either indirect fluorescent antibody (IFA) or multiplex bead assay helps support a diagnosis of Goodpasture syndrome.  However, the combined result of both assays performed during initial evaluation improves the diagnostic sensitivity for disease. A positive result in one or both assays should be confirmed by renal biopsy.

Administrative

CPT Codes

83516; 86255

GLUCAGON

LAB1005

Collect

Protease Inhibitor tube (PPACK; Phe-Pro-Arg-cholormethylketone).

Specimen Preparation

Protease Inhibitor tube (ARUP supply #49662), available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. A winged collection set must be used. NOT RECOMMENDED: Filling collection tubes directly through a needle/tube-holder assembly increases the risk of chemical reflux back into the vein of the patient. WARNING: Collection tubes are NOT STERILE. Mix Collection tube thoroughly. Separate the plasma from cells within 1 hour of collection by centrifugation. Transfer 1 mL plasma to an ARUP Standard Transport Tube and freeze. (Min: 0.5 mL) Do not submit the collection tube for testing.

Unacceptable Conditions

Grossly hemolyzed specimens.

Storage/Transport Temperature

Requires Special Handling: Special collection kit must be obtained from PCL Clinical Lab. Call 720-848-4401 to obtain kit.

Stability (from collection to initiation)

After separation from cells: Ambient: Unacceptable; Refrigerated: 48 hours; Frozen: 3 months

Performed by

PCL Clinical Laboratory

Performed

Tue

Methodology

Quantitative Radioimmunoassay

Reported

3-11 days

Synonyms

  • LAB1005

Ordering Recommendations

Aids in diagnosis and monitoring of glucagonoma.

Reference Interval

Effective December 1, 2014
Adult: Less than or equal to 208 ng/L

Performed by

PCL Clinical Laboratory

CPT Codes

82943
Collection

LAB1005

Collect

Protease Inhibitor tube (PPACK; Phe-Pro-Arg-cholormethylketone).

Specimen Preparation

Protease Inhibitor tube (ARUP supply #49662), available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. A winged collection set must be used. NOT RECOMMENDED: Filling collection tubes directly through a needle/tube-holder assembly increases the risk of chemical reflux back into the vein of the patient. WARNING: Collection tubes are NOT STERILE. Mix Collection tube thoroughly. Separate the plasma from cells within 1 hour of collection by centrifugation. Transfer 1 mL plasma to an ARUP Standard Transport Tube and freeze. (Min: 0.5 mL) Do not submit the collection tube for testing.

Unacceptable Conditions

Grossly hemolyzed specimens.

Storage/Transport Temperature

Requires Special Handling: Special collection kit must be obtained from PCL Clinical Lab. Call 720-848-4401 to obtain kit.

Stability (from collection to initiation)

After separation from cells: Ambient: Unacceptable; Refrigerated: 48 hours; Frozen: 3 months

Performed by

PCL Clinical Laboratory

Ordering

Performed

Tue

Methodology

Quantitative Radioimmunoassay

Reported

3-11 days

Synonyms

  • LAB1005

Ordering Recommendations

Aids in diagnosis and monitoring of glucagonoma.
Result Interpretation

Reference Interval

Effective December 1, 2014
Adult: Less than or equal to 208 ng/L

Performed by

PCL Clinical Laboratory

Administrative

CPT Codes

82943

GLUCOSE 1 HOUR

LAB3436

 

Collect

One 4.5 mL green top with gel (PST), lithium heparin plasma.

 

Pediatric Collection

Minimum volume: 0.2 mL plasma

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.

Offsite: Centrifuge within 30 minutes of collection. Transport to laboratory at ambient temperature.

 

Stability (from collection to initiation)

Before centrifugation: Ambient, 1 hour.

 After centrifugation: Ambient, 8 hours; Refrigerated, 3 days; Frozen, Unacceptable.

Plasma Aliquot: Ambient, 8 hours; Refrigerated, 3 days; Frozen (-20 degrees C), 1 year.

Performed by

PCL Clinical Laboratory - Core Chemistry

Performed

Upon receipt

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • LAB3436

Interpretive Data

No fasting is required.  If a one hour, 50G glucose dose, value is equal to or exceeds 135 mg/dL; performance of an oral 3 hour glucose tolerance test using a 100G glucose dose is indicated to determine GDM status. REFERENCE:  American Diabetes Association Position Statement. Diabetes Care  2002; 25:S21-24

Performed by

PCL Clinical Laboratory - Core Chemistry

CPT Codes

82951 for glucose tolerance test (GTT), 3 specimens

82952 for each additional glucose test beyond three tolerance test specimens

Collection

LAB3436

 

Collect

One 4.5 mL green top with gel (PST), lithium heparin plasma.

 

Pediatric Collection

Minimum volume: 0.2 mL plasma

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.

Offsite: Centrifuge within 30 minutes of collection. Transport to laboratory at ambient temperature.

 

Stability (from collection to initiation)

Before centrifugation: Ambient, 1 hour.

 After centrifugation: Ambient, 8 hours; Refrigerated, 3 days; Frozen, Unacceptable.

Plasma Aliquot: Ambient, 8 hours; Refrigerated, 3 days; Frozen (-20 degrees C), 1 year.

Performed by

PCL Clinical Laboratory - Core Chemistry

Ordering

Performed

Upon receipt

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • LAB3436
Result Interpretation

Interpretive Data

No fasting is required.  If a one hour, 50G glucose dose, value is equal to or exceeds 135 mg/dL; performance of an oral 3 hour glucose tolerance test using a 100G glucose dose is indicated to determine GDM status. REFERENCE:  American Diabetes Association Position Statement. Diabetes Care  2002; 25:S21-24

Performed by

PCL Clinical Laboratory - Core Chemistry

Administrative

CPT Codes

82951 for glucose tolerance test (GTT), 3 specimens

82952 for each additional glucose test beyond three tolerance test specimens

GLUCOSE BODY FLUID

LAB186

GLU BF

Collect

1 mL fluid in sterile container

Minimum volume: 0.2mL

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume. Synovial Fluid

Storage/Transport Temperature

Internal: Deliver to lab immediately
Offsite: Refrigerate.

Stability (from collection to initiation)

Room temp: 1 hour; Refrigerated: (free of cells) 1 week; Frozen: (free of cells) 6 months.

Remarks

Identify fluid source on requisition. Synovial fluid, because of specimen viscosity is not a valid sample type.

Performed by

PCL Clinical Laboratory

Performed

Daily

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • LAB186
  • GLU BF

Interpretive Data

The reference range for glucose in body fluids is undefined.  The result must be integrated into the clinical context and/or compared to a synchronous serum or plasma measurement. 
This test was developed and its performance characteristics determined by University of Colorado Hospital.  It has not been cleared or approved by the FDA.  The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.

Performed by

PCL Clinical Laboratory

CPT Codes

82945

Collection

LAB186

GLU BF

Collect

1 mL fluid in sterile container

Minimum volume: 0.2mL

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume. Synovial Fluid

Storage/Transport Temperature

Internal: Deliver to lab immediately
Offsite: Refrigerate.

Stability (from collection to initiation)

Room temp: 1 hour; Refrigerated: (free of cells) 1 week; Frozen: (free of cells) 6 months.

Remarks

Identify fluid source on requisition. Synovial fluid, because of specimen viscosity is not a valid sample type.

Performed by

PCL Clinical Laboratory

Ordering

Performed

Daily

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • LAB186
  • GLU BF
Result Interpretation

Interpretive Data

The reference range for glucose in body fluids is undefined.  The result must be integrated into the clinical context and/or compared to a synchronous serum or plasma measurement. 
This test was developed and its performance characteristics determined by University of Colorado Hospital.  It has not been cleared or approved by the FDA.  The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.

Performed by

PCL Clinical Laboratory

Administrative

CPT Codes

82945

GLUCOSE CSF

LAB185

GLU CSF

 

Collect

1 mL CSF in sterile container [ Min Vol: 0.2 mL]

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately
Offsite: Refrigerate.

Stability (from collection to initiation)

Room temp: 1 hour; Refrigerated: (free of cells) 1 week; Frozen: (free of cells) 6 months.

Performed by

PCL Clinical Laboratory

Performed

Daily

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • LAB185
  • GLU CSF
  • GLUCOSE CEREBROSPINAL FLUID

Reference Interval

Effective 05/20/2014:

Age 0 min - 12 yrs, 60 - 80 mg/dL

Age 12 yrs - 150 yrs, 40 - 70 mg/dL

 

Before 05/20/2014:

40-80 mg/dL

Performed by

PCL Clinical Laboratory

CPT Codes

82945

Collection

LAB185

GLU CSF

 

Collect

1 mL CSF in sterile container [ Min Vol: 0.2 mL]

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately
Offsite: Refrigerate.

Stability (from collection to initiation)

Room temp: 1 hour; Refrigerated: (free of cells) 1 week; Frozen: (free of cells) 6 months.

Performed by

PCL Clinical Laboratory

Ordering

Performed

Daily

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • LAB185
  • GLU CSF
  • GLUCOSE CEREBROSPINAL FLUID
Result Interpretation

Reference Interval

Effective 05/20/2014:

Age 0 min - 12 yrs, 60 - 80 mg/dL

Age 12 yrs - 150 yrs, 40 - 70 mg/dL

 

Before 05/20/2014:

40-80 mg/dL

Performed by

PCL Clinical Laboratory

Administrative

CPT Codes

82945

GLUCOSE FASTING

LAB81

Collect

One 4.5 mL Green top with gel (PST), (lithium heparin plasma).

Pediatric Collection

At least 0.5 mL whole blood collected in a microtainer, green top with gel, lithium heparin plasma.

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Centrifuge within 30 minutes of collection. Transport to laboratory at 2-8 degrees C.

Stability (from collection to initiation)

Before centrifugation: Ambient, 1 hour.

After centrifugation: Ambient, 8 hours; Refrigerated, 3 days; Frozen, Unacceptable.

Plasma Aliquot: Ambient, 8 hours; Redfrigerated, 3 days; Frozen, 1 year.

Remarks

Patient should be fasting for 8 hours prior to draw.

Performed by

PCL Clinical Laboratory - Core

Performed

Daily

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • -131
  • LAB81

Reference Interval

Effective 05/20/2014:

70 - 105 mg/dL

 

Before 05/20/2014:

Sex From Age To Age Normal Low Normal High Units
M/F 0 1M 40 110 mg/dL
M/F 1M 16 60 105 mg/dL
M/F 16 150 70 105 mg/dL

Interpretive Data

Effective 05/20/2014:

Following an overnight fast of 8-14 hours, a value equal to or greater than 126 mg/dL is indicative of Diabetes Mellitus and should be confirmed by repeat testing, on a subsequent day, to establish the diagnosis of DM. REFERENCE:  American Diabetes Association Position Statement. Diabetes Care 2002; 25:S21-S24

 

Before 05/20/2014:

Following an overnight fast of 8-14 hours, a value equal to or greater than 126 mg/dL is indicative of Diabetes Mellitus and should be confirmed by repeat testing, on a subsequent day, to establish the diagnosis of DM.
REFERENCE: American Diabetes Association Position Statement. Diabetes Care 2002; 25:S21-S24

Performed by

PCL Clinical Laboratory - Core

CPT Codes

82947

Collection

LAB81

Collect

One 4.5 mL Green top with gel (PST), (lithium heparin plasma).

Pediatric Collection

At least 0.5 mL whole blood collected in a microtainer, green top with gel, lithium heparin plasma.

Unacceptable Conditions

Sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Centrifuge within 30 minutes of collection. Transport to laboratory at 2-8 degrees C.

Stability (from collection to initiation)

Before centrifugation: Ambient, 1 hour.

After centrifugation: Ambient, 8 hours; Refrigerated, 3 days; Frozen, Unacceptable.

Plasma Aliquot: Ambient, 8 hours; Redfrigerated, 3 days; Frozen, 1 year.

Remarks

Patient should be fasting for 8 hours prior to draw.

Performed by

PCL Clinical Laboratory - Core

Ordering

Performed

Daily

Methodology

O2 depletion-Enzymatic

Reported

Same day

Synonyms

  • -131
  • LAB81
Result Interpretation

Reference Interval

Effective 05/20/2014:

70 - 105 mg/dL

 

Before 05/20/2014:

Sex From Age To Age Normal Low Normal High Units
M/F 0 1M 40 110 mg/dL
M/F 1M 16 60 105 mg/dL
M/F 16 150 70 105 mg/dL

Interpretive Data

Effective 05/20/2014:

Following an overnight fast of 8-14 hours, a value equal to or greater than 126 mg/dL is indicative of Diabetes Mellitus and should be confirmed by repeat testing, on a subsequent day, to establish the diagnosis of DM. REFERENCE:  American Diabetes Association Position Statement. Diabetes Care 2002; 25:S21-S24

 

Before 05/20/2014:

Following an overnight fast of 8-14 hours, a value equal to or greater than 126 mg/dL is indicative of Diabetes Mellitus and should be confirmed by repeat testing, on a subsequent day, to establish the diagnosis of DM.
REFERENCE: American Diabetes Association Position Statement. Diabetes Care 2002; 25:S21-S24

Performed by

PCL Clinical Laboratory - Core

Administrative

CPT Codes

82947

More Articles...